[Therapeutic effect of menaquinone-4 (K2) on hypoprothrombinemia caused by warfarin].
D000284:Administration, Oral; D000818:Animals; D005163:Factor Analysis, Statistical; D007020:Hypoprothrombinemias / Q000139:chemically induced / Q000188:drug therapy*; D007273:Injections, Intramuscular; D008297:Male; D011517:Prothrombin Time; D011817:Rabbits; D014812:Vitamin K / Q000008:administration & dosage / Q000627:therapeutic use*; D010837:Vitamin K 1 / Q000627:therapeutic use; D014859:Warfarin / Q000008:administration & dosage
D014812:Vitamin K; D014859:Warfarin; D010837:Vitamin K 1